A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2'-deoxyguanosine after ultraviolet-A irradiation

Toxicology and Applied Pharmacology

Volumn 145, Issue 2, 1997, Pages 381-387

  Rosen, J E ^a,c   Chen, D ^a   Prahalad, A K ^a,d   Spratt, T E ^a   Schluter, G ^b   Williams, G M ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b BAYER AG   (Germany)

^c US EPA ^*  (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BAYER 12 8039; BAYER Y3118; DEOXYGUANOSINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EPITHELIUM CELL; LIVER CELL; NONHUMAN; PHOTODEGRADATION; PHOTOTOXICITY; RAT; ULTRAVIOLET A RADIATION;

ANIMALIA;

EID: 0031213558     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8183     Document Type: Article

References (46)

1. Baes H. Photosensitivity caused by nalidixic acid. Dermatologica. 136:1968;61-64.
2. Baran R., Brun P. Photoonycholoysis induced by the fluoroquinolones pefloxacin and ofloxacin. Report on two cases. Dermatologia. 173:1986;85-88.
3. Birkett D. A., Garrets M., Stenson C. J. Phototoxic bullous eruptions due to nalidixic acid. Br. J. Dermatol. 81:1969;342-344.
4. Bowie W. R., Willets V., Jewesson P. J. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin. Antimicrob. Agents Chemother. 33:1989;1778-1782.
5. Brendler-Schwaab S. Y., von-Keutz E., Schluter G., Herbold B. A. A new approach to screen for photomutagenicity with the HPRT-assay. Photocarcinogenesis, Mechanisms, Models and Human Health Implications. 1995.
6. Christ W., Lehnert T., Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect. Dis. 10:1988;S141-S146.
7. Domagala J. M. Structure-activity and structure side effects relationship for the quinolone anitbacterials. J. Antimicrob. Chemother. 33:1994;685-706.
8. Ferguson J., Walker E. M., Johnson B. E. Quinolone antibiotic-induced phototoxicity. Br. J. Dermatol. 120:1989;291.
9. Ferguson J., Johnson B. E. Ciprofloxacin-induced photosensitivity:In vitroin vivo. Br. J. Dermatol. 123:1990;9-20.
10. Fernández E. B., Cádenas A. M. G. The mechanism of photohemolysis by photoproducts of nalidixic acid. Photochem Photobiol. B4:1990;329-333.
11. Fiala E. S., Conaway C. C., Mathis J. E. Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane. Cancer Res. 49:1989;5518-5522.
12. Floyd R. A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 11:1990;1447-1450.
13. Floyd R. A., Watson J. J., Wong P. K., Altmiller D. H., Rickard R. C. Hydroxyl free radical adduct of deoxyguanosine sensitive detection and mechanism of formation. Free Radical Res. Commun. 1:1986;163-172.
14. Script. 1807:1993;19.
15. A. Forsgren, R. Neringer, C. Hansson, B. Ode, 1990, Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: Three day versus seven-day treatment, 30th ICAAC.
16. Grobe K. The importance of the cycloaracylation process for the synthesis of modern fluoroquinolones. J. Prakt. Chem. 335:1993;397-409.
17. Halkin H. Adverse effects of the fluoroquinolones. Rev. Infect. Dis. 10:1988;S258-S261.
18. Kasai H., Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 12:1984;2137-2145.
19. Kawabe Y., Mizuno N., Sakakibara S. Photoallergic reaction caused by enoxacin. Photodermatol. 6:1989;58-60.
20. Loveday K. S. Interrelationship of photocarcinogenicity, photomutagenicity and phototoxicity. Photochem. Photobiol. 63:1996;369-372.
21. Marmur J. A procedure for the isolation of deoxyribonucleic acid from microorganisms. J. Mol. Biol. 3:1961;208-218.
22. Marutani K., Matsumoto M., Otabe Y., Nagamuta M., Tanaka K., Miyoshi A., Hasegawa T., Nagano H., Matsubara S., Kamide R., Yokota T., Matsumoto F., Ueda Y. Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light. Antimicrob. Agents Chemother. 37:1993;2217-2223.
23. Matsumoto M., Kojima K., Nagano H., Matsubara S., Yokota T. Photostability an biological activity of fluoroquinolones substituted at the 8 position after UV irradiation. Antimicrob. Agents Chemother. 36:1992;1715-1719.
24. Moriya M., Ou C., Bodepudi V., Johnson F., Takeshita M., Grollman A. P. Site-specific mutagenesis using a gapped duplex vector: A study of translesion synthesis past 8-oxodeoxyguanosine in E. coli. Mutat. Res. 1991;281-288.
25. nd, Anaheim.
26. th, New Orleans.
27. Petersen U., Bartel S., Bremm K-D., Himmler T., Krebs A., Schenke T. The synthesis and biological properties of 6-fluoroquinolonecarboxylic acids. Bull Soc. Chim. Belg. 105:1996b;683-699.
28. Petri H., Tronnier H. Efficacy of enoxacin in the treatment of bacterial infections of the skin with regards to photosensitization. Infection. 14:1986;S213-S216.
29. Philips G., Johnson B. E., Ferguson J. The loss of antibiotic activity of ciprofloxacin by photodegradation. J. Antimicrob. Chemother. 26:1990;783-789.
30. Pryzbilla B., Ring J., Ruzicka T., Whir G. In vitro. J. Invest. Dermatol. 89:1987;444.
31. Ramsay C. H., Obreshfova B. Phototoxicity from nalidixic acid. Br. J. Dermatol. 91:1974;523-528.
32. Raoul S., Rosen J. E., Williams G. M., Cadet J. Photodynamic mechanism for lomefloxacin after UVA exposure in the presence of 2′-deoxyguonosine or ARL-18 cells. American Society for Photobiology, 23rd Annual Meeting, Wash. DC. Photochem. Photobiol. 61:1995.
33. Robertson D. G., Epling G. A., Kiely J. S., Bailey D. L., Song B. Mechanistic studies of the phototoxic potential of PD 117596 a quinolone antibacterial compound. Toxicol. Appl. Pharmacol. 111:1991;221-232.
34. 22. Photochem. Photobiol. 64:1996;117-122.
35. Rosen J. E., Prahalad A. K., Schluter G., Chen D., Williams G. M. Quinolone antibiotic photodynamic production of 8-oxo-deoxyguanosine in cultured liver epithelial cells. Photochem. Photobiol. 1997.
36. Shelley E. D., Shelley W. B. The subcorneal pustular drug eruption: An example induced by norfloxacin. Cutis. 42:1988;24-27.
37. Shimoda K., Yoshida M., Wagai N., Takayama S., Kato M. Phototoxic lesions induced by quinolone antibacterial agents in auricular skin and retina of albino mice. Toxicol. Pathol. 21:1993;554-561.
38. Sterenborg H. J. C. M., van der Leun J. C. Tumorigenesis by a long wavelength UV-A source. Photochem. Photobiol. 51:1990;325-330.
39. Strickland P. T. Photocarcinogenesis by near-ultraviolet (UVA) radiation in sencar mice. J. Invest. Dermatol. 87:1986;272-275.
40. Sugiura K., Tsuruta K., Noda H., Morita K., Umemura Y. Photo-induced drug eruption from enoxacin. Rinsho Derma. 29:1987;151-154.
41. Tokura Y., Nishijima T., Yagi H., Furukawa F., Takigawa M. Photohaptenic properties of fluoroquinolones. Photochem. Photobiol. 64:1996;838-844.
42. Wadworth A. N., Goa K. L. Lomefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 42:1991;1018-1060.
43. Wagai N., Tawara K. Important role of oxygen metabolites in quinolone antibacterial agent-induced phototoxicity in Balb/c mice. Arch. Toxicol. 65:1991;495-497.
44. Wagai N., Tawara K. Possible reasons for differences in phototoxic potential of 5 quinolone antibacterial agents: Generation of toxic oxygen. Free Rad. Res. Commun. 17:1992a;387-398.
45. Wagai N., Tawara K. Possible direct role of reactive oxygens in the cause of cutaneous phototoxicity induced by five quinolones in mice. Arch. Toxicol. 66:1992b;392-397.
46. Williams G. M., Gunn J. M. Long-term cell culture of adult rat liver epithelial cells. Exp. Cell Res. 89:1974;139-142.